← Back to news
NewsFRONTIERS IN ONCOLOGYMonday, April 13, 2026 · April 13, 2026

Editorial: Treatment response and resistance to targeted therapies for NSCLC.

WHY IT MATTERS

Recent peer-reviewed research on Small cell lung cancer that may be relevant for patients and caregivers.

Editorial: Treatment response and resistance to targeted therapies for NSCLC.

Read on PubMed
Read the original at Frontiers in oncology
ResearchPubMedSmall cell lung cancer

Related conditions

Small cell lung cancer

Related news

Int J Circumpolar Health · -222 days ago
A population-based legacy study of myasthenia gravis in Iceland: insights from a small Arctic nation
Published in Int J Circumpolar Health. Hjaltason H et al.
Health Inf Sci Syst · -192 days ago
PhenoRareAI: Phenotype-based intelligent diagnosis for rare neuromuscular disorders of glycogen storage disease and spinal muscular atrophy
Published in Health Inf Sci Syst. Zhai W et al.
Ther Adv Rare Dis · -192 days ago
Could an outcome-based agreement be operationalized using real-world data from the Canadian Neuromuscular Disease Registry? Perspectives from an expert-led assessment in spinal muscular atrophy
Published in Ther Adv Rare Dis. Mitha A et al.
J Allergy Clin Immunol Glob · -39 days ago
Emerging trends and research hot spots in inborn error of immunity: A bibliometric perspective
Published in J Allergy Clin Immunol Glob. Alblooshi H et al.